Amélie Anota

2.5k total citations
111 papers, 1.2k citations indexed

About

Amélie Anota is a scholar working on Oncology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Amélie Anota has authored 111 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 40 papers in Economics and Econometrics and 20 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Amélie Anota's work include Cancer survivorship and care (46 papers), Health Systems, Economic Evaluations, Quality of Life (34 papers) and Childhood Cancer Survivors' Quality of Life (19 papers). Amélie Anota is often cited by papers focused on Cancer survivorship and care (46 papers), Health Systems, Economic Evaluations, Quality of Life (34 papers) and Childhood Cancer Survivors' Quality of Life (19 papers). Amélie Anota collaborates with scholars based in France, Italy and United Kingdom. Amélie Anota's co-authors include Franck Bonnetain, Caroline Mollévi, Fabio Efficace, Francesco Cottone, Frédéric Fiteni, Virginie Westeel, Virginie Nerich, Mariette Mercier, Sophie Paget‐Bailly and Véronique Christophe and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Amélie Anota

105 papers receiving 1.2k citations

Peers

Countries citing papers authored by Amélie Anota

Since Specialization

Citations

This map shows the geographic impact of Amélie Anota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Anota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Anota more than expected).

Fields of papers citing papers by Amélie Anota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amélie Anota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Anota. The network helps show where Amélie Anota may publish in the future.

Co-authorship network of co-authors of Amélie Anota

This figure shows the co-authorship network connecting the top 25 collaborators of Amélie Anota. A scholar is included among the top collaborators of Amélie Anota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amélie Anota. Amélie Anota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of a one-year supervised physical activity program on long-term cancer-related fatigue and mediating effects of the gut microbiota in metastatic testicular cancer patients: protocol of the prospective multicentre, randomized controlled phase-III STARTER trial 2024 ·BMC Cancer ·Hwayoung Noh, Amélie Anota, (unknown), (unknown), (unknown), Camille Schiffler, (unknown), Sabina Rinaldi, Joël Lachuer, Pekka Keski‐Rahkonen, Marc J. Gunter, Aude Fléchon, Béatrice Fervers, Olivia Pérol	2
2	Remission after CAR T‐cell therapy: Do lymphoma patients recover a normal life? 2024 ·HemaSphere ·(unknown), (unknown), (unknown), Amélie Anota, Faustine Lhomme, Guillaume Manson, Sophie de Guibert, (unknown), (unknown), (unknown), Sandra De Barros, Loïc Ysebaert, (unknown), Mélanie Cogne, (unknown), Roch Houot, Aline Moignet	3
3	Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA study 2024 ·Supportive Care in Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), Bénédicte Mastroïanni, Hélène Vanacker, Armelle Vinceneux, Mehdi Brahmi, (unknown), Loïc Verlingue, Mona Amini‐Adlé, Aurélie Swalduz, Julien Gautier, Françoise Ducimetière, Amélie Anota, Philippe A. Cassier, Gisèle Chvetzoff, Véronique Christophe	0
4	Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial 2023 ·Journal of the National Comprehensive Cancer Network ·Cindy Neuzillet, Olivier Bouché, Christophe Tournigand, Benoist Chibaudel, (unknown), Leïla Bengrine-Lefèvre, (unknown), May Mabro, Jean‐Philippe Metges, Denis Péré-Vergé, Thierry Conroy, Astrid Lièvre, (unknown), Françoise Desseigne, François Goldwasser, Julie Henriques, Amélie Anota, Pascal Hammel	13
5	Pre-operative and early postoperative health-related quality of life of breast cancer woman: a Lebanese prospective study 2023 ·BMC Women s Health ·(unknown), Virginie Nerich, Linda Abou‐Abbas, Fadi Abdel‐Sater, Amélie Anota	3
6	Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study 2022 ·Clinical Genetics ·Anne Brédart, Antoine De Pauw, (unknown), (unknown), Amélie Anota, Kerstin Rhiem, Rita K. Schmutzler, (unknown), Peter Devilee, Dominique Stoppa‐Lyonnet, Jean‐Luc Kop, Sylvie Dolbeault	2
7	A synthesis of response shift effects in quantitative health research: A systematic review and meta-regression protocol 2022 ·Richard Sawatzky, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Amélie Anota, (unknown), M. A. G. Sprangers, (unknown), (unknown)	1
8	Reasons for acceptance and refusal of early palliative care in patients included in early-phase clinical trials in a regional comprehensive cancer centre in France: protocol for a qualitative study 2022 ·BMJ Open ·Gisèle Chvetzoff, (unknown), (unknown), (unknown), (unknown), Bénédicte Mastroïanni, Hélène Vanacker, Armelle Vinceneux, Mehdi Brahmi, (unknown), Julien Gautier, (unknown), Françoise Ducimetière, Amélie Anota, Philippe A. Cassier, Véronique Christophe	2
9	Time to health-related quality of life improvement analysis was developed to enhance evaluation of modern anticancer therapies 2020 ·Journal of Clinical Epidemiology ·Francesco Cottone, Gary S. Collins, Amélie Anota, Kathrin Sommer, Johannes M. Giesinger, Jacobien M. Kieffer, Neil K. Aaronson, Kristel Van Steen, (unknown), Fausto Castagnetti, Paola Fazi, Marco Vignetti, David Cella, Fabio Efficace	9
10	Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results 2020 ·Quality of Life Research ·Caroline Mollévi, (unknown), C. Bourgier, Thierry Conroy, Bruno Chauffert, Mohamed Hebbar, William Jacot, Béata Juzyna, Hélène de Forges, Sophie Gourgou, Franck Bonnetain, Célia Touraine, Amélie Anota	10
11	Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial 2019 ·Clinical Cancer Research ·Guillaume Eberst, Amélie Anota, Arnaud Scherpereel, Julien Mazières, J. Margery, Laurent Greillier, Clarisse Audigier-Valette, Denis Moro‐Sibilot, Olivier Molinier, H. Léna, F. Rivière, I. Monnet, V. Gounant, Henri Janicot, Radj Gervais, (unknown), (unknown), Franck Morin, Gérard Zalcman, Virginie Westeel	15
12	The “Psychosocial Aspects in Hereditary Cancer” questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French‐, German‐ and Spanish‐language versions 2019 ·European Journal of Cancer Care ·Anne Brédart, Amélie Anota, (unknown), Alejandra Cano, Antoine De Pauw, Jean‐Luc Kop, Neil K. Aaronson, Eveline M. A. Bleiker, Joan Brunet, Peter Devilee, Dominique Stoppa‐Lyonnet, (unknown), Sylvie Dolbeault	3
13	Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study 2019 ·BMJ Open ·Anne Brédart, Jean‐Luc Kop, (unknown), Alejandra Cano, Antoine De Pauw, Amélie Anota, Joan Brunet, Peter Devilee, Dominique Stoppa‐Lyonnet, Rita K. Schmutzler, Sylvie Dolbeault	9
14	Patient-Centered Care in Breast Cancer Genetic Clinics 2018 ·International Journal of Environmental Research and Public Health ·Anne Brédart, Amélie Anota, (unknown), (unknown), Olivier Lareyre, Antoine De Pauw, Alejandra Cano, Dominique Stoppa‐Lyonnet, Rita K. Schmutzler, Sylvie Dolbeault, Jean‐Luc Kop	9
15	Ethical leadership, professional caregivers' well-being, and patients' perceptions of quality of care in oncology 2018 ·European Journal of Oncology Nursing ·Nicolas Gillet, Evelyne Fouquereau, Hélène Coillot, Franck Bonnetain, Sophie Dupont, L. Moret, Amélie Anota, Philippe Colombat	18
16	An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma 2016 ·BMJ Open ·Amélie Anota, Mathieu Boulin, Tienhan Sandrine Dabakuyo‐Yonli, Patrick Hillon, Jean–Pierre Cercueil, Anne Minello, Jean–Louis Jouve, Xavier Paolettí, Laurent Bedenne, Boris Guiu, Franck Bonnetain	11
17	Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review 2016 ·BMC Cancer ·Frédéric Fiteni, Amélie Anota, Virginie Westeel, Franck Bonnetain	31
18	A longitudinal analysis of patient satisfaction with care and quality of life in ambulatory oncology based on the OUT-PATSAT35 questionnaire 2014 ·BMC Cancer ·(unknown), Amélie Anota, Anne Brédart, Alain Monnier, Jean-François Bosset, Mariette Mercier	37
19	Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study 2014 ·Health and Quality of Life Outcomes ·Amélie Anota, (unknown), M. Savina, (unknown), S. Gourgou-Bourgade, Franck Bonnetain, Caroline Mollévi	13
20	Statistical challenges of quality of life and cancer: new avenues for future research 2013 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Laurent Boyer, Karine Baumstarck, Pierre Michel, Mohamed Boucékine, Amélie Anota, Franck Bonnetain, Joël Coste, Bruno Falissard, Alice Guilleux, Jean-Benoît Hardouin, Anderson Loundou, Mariette Mercier, Mounir Mesbah, Alexandra Rouquette, Véronique Sebille, Mathilde G. E. Verdam, Badih Ghattas, Françis Guillemin, Pascal Auquier	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact